Cargando…
Exploiting Prophage-Mediated Lysis for Biotherapeutic Release by Lactobacillus reuteri
Lactobacillus reuteri has the potential to be developed as a microbial therapeutic delivery platform because of an established safety profile, health-promoting properties, and available genome editing tools. Here, we show that L. reuteri VPL1014 exhibits a low mutation rate compared to other Gram-po...
Autores principales: | Alexander, Laura M., Oh, Jee-Hwan, Stapleton, Donald S., Schueler, Kathryn L., Keller, Mark P., Attie, Alan D., van Pijkeren, Jan-Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6498169/ https://www.ncbi.nlm.nih.gov/pubmed/30683744 http://dx.doi.org/10.1128/AEM.02335-18 |
Ejemplares similares
-
Secretion of Recombinant Interleukin-22 by Engineered Lactobacillus reuteri Reduces Fatty Liver Disease in a Mouse Model of Diet-Induced Obesity
por: Oh, Jee-Hwan, et al.
Publicado: (2020) -
Prophages in Lactobacillus reuteri Are Associated with Fitness Trade-Offs but Can Increase Competitiveness in the Gut Ecosystem
por: Oh, Jee-Hwan, et al.
Publicado: (2019) -
CRISPR–Cas9-assisted recombineering in Lactobacillus reuteri
por: Oh, Jee-Hwan, et al.
Publicado: (2014) -
Gut Symbionts Lactobacillus reuteri R2lc and 2010 Encode a Polyketide Synthase Cluster That Activates the Mammalian Aryl Hydrocarbon Receptor
por: Özçam, Mustafa, et al.
Publicado: (2019) -
Genome alterations associated with improved transformation efficiency in Lactobacillus reuteri
por: Ortiz-Velez, Laura, et al.
Publicado: (2018)